References
- Pierre DM, Baron J, Yu VL, et al. Diagnostic testing for Legionnaires’ disease. Ann Clin Microbiol Antimicrob. 2017;16(1):59. doi:10.1186/s12941-017-0229-6
- Dagan A, Epstein D, Mahagneh A, et al. Community-acquired versus nosocomial Legionella pneumonia: factors associated with Legionella-related mortality. Eur J Clin Microbiol Infect Dis. 2021;40(7):1419–1426. doi:10.1007/s10096-021-04172-y
- Viasus D, Gaia V, Manzur-Barbur C, et al. Legionnaires’ disease: update on diagnosis and treatment. Infect Dis Ther. 2022;11(3):973–986. doi:10.1007/s40121-022-00635-7
- Nielsen K, Bangsborg JM, Hoiby N. Susceptibility of Legionella species to five antibiotics and development of resistance by exposure to erythromycin, ciprofloxacin, and rifampicin. Diagn Microbiol Infect Dis. 2000;36(1):43–48. doi:10.1016/S0732-8893(99)00095-4
- Liu X, Shin S. Viewing Legionella pneumophila pathogenesis through an immunological lens. J Mol Biol. 2019;431(21):4321–4344. doi:10.1016/j.jmb.2019.07.028
- Soda EA, Barskey AE, Shah PP, et al. Vital signs: health care associated legionnaires’ disease surveillance data from 20 states and a large metropolitan area-United States, 2015. Am J Transplant. 2017;17(8):2215–2220. doi:10.1111/ajt.14407
- Mondino S, Schmidt S, Rolando M, et al. Legionnaires’ disease: state of the art knowledge of pathogenesis mechanisms of Legionella. Annu Rev Pathol. 2020;15:439–466. doi:10.1146/annurev-pathmechdis-012419-032742
- Cunha BA, Burillo A, Bouza E Legionnaires’ disease. Lancet. 2016;387(10016):376–385. PMID: 26231463. doi:10.1016/S0140-6736(15)60078-2
- Dalal N, Athwal PSS, Tharu B, et al. Legionnaires disease presenting as diarrhea: a case report. Cureus. 2020;12(9):e10593. doi:10.7759/cureus.10593
- Chahin A, Opal MS. Severe pneumonia caused by Legionella pneumophila: differential diagnosis and therapeutic considerations. Infect Dis Clin North Am. 2017;31(1):111–121. doi:10.1016/j.idc.2016.10.009
- Beg M, Arif H, Walsh T. Community-acquired pneumonia secondary to Legionella pneumophila and Streptococcus pneumoniae: a rare co-infection. Cureus. 2019;11(2):e4080. doi:10.7759/cureus.4080
- Chahin A, Opal SM. Severe pneumonia caused by Legionella pneumophila. Infect Dis Clin N Am. 2017;31(1):111–121.
- Mittal S, Singh AP, Gold M, et al. Thoracic imaging features of legionnaire’s disease. Infect Dis Clin North Am. 2017;31(1):43–54. doi:10.1016/j.idc.2016.10.004
- Kakeya H, Ehara N, Fukushima K, et al. Severe Legionnaires’ disease successfully treated using a combination of fluoroquinolone, erythromycin, corticosteroid, and sivelestat. Inter Med. 2008;47:773–777. doi:10.2169/internalmedicine.47.0677
- Bauer G, Berens C, Projan SJ, et al. Comparison of tetracycline and tigecycline binding to ribosomes mapped by dimethylsulphate and drug-directed Fe2+ cleavage of 16S rRNA. J Antimicrob Chemother. 2004;53(4):592–599. doi:10.1093/jac/dkh125
- Slawek D, Altshuler D, Dubrovskaya Y, et al. Tigecycline as a second-line agent for Legionnaires’ disease in severely ill patients. BRIEF REPORT. 2017;4(4):1–3.
- Galstain GM, Drokov MY, Katrysh SA, et al. A case of legionellesis pneumonia verified by isolation of Legionella pneumophila serogroup 1 from bronchoalveolar lavage fluid treated with levofloxacine and tigecycline. J Ter Arkh. 2011;83(7):61–65.
- Valve K, Vaalasti A, Vj A, et al. Disseminated Legionella pneumophila infection in an immunocompromised patient treated with tigecycline. J Scand J Infect Dis. 2010;42(2):152–155. doi:10.3109/00365540903359895
- Snijders D, Daniels JM, de Graaff CS, et al. Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial. Am J Respir Crit Care Med. 2010;181(9):975–982. doi:10.1164/rccm.200905-0808OC